Epidemiologic observations on the natural course of pemphigus vulgaris

International Journal of Dermatology

Volumn 37, Issue 3, 1998, Pages 215-219

  Kyriakis, Kyriakos P ^a   Tosca, Androniki D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G;

ANTIBODY TITER; ARTICLE; BULLOUS SKIN DISEASE; CLINICAL ARTICLE; CLINICAL OBSERVATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FAMILIAL DISEASE; FEMALE; HUMAN; IONIZING RADIATION; MALE; MORTALITY; NEOPLASM; PEMPHIGUS VULGARIS; RELAPSE; SEROLOGY; SKIN MANIFESTATION;

ADULT; AGED; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; PROSPECTIVE STUDIES; RECURRENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 0031936340     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00317.x     Document Type: Article

References (26)

1. Kyriakis K, Tosca A, Lehou J, et al. A five year retrospective study on pemphigus and pemphigoid. Australas J Dermatol 1989; 30: 33-36.
2. Kyriakis KP, Vareltzidis AG, Tosca AD. Environmental factors influencing the biological behavior patterns of pemphigus vulgaris: epidemiologic approach. Int J Dermatol 1995; 34: 181-185.
3. Bystryn JC. Therapy of pemphigus. Semin Dermatol 1988; 7: 186-194.
4. Doane DP, ed. Exploring Statistics with the IBM PC, 2nd edn. Reading, MA: Addison Wesley Publishing Co., 1988.
5. Kyriakis K, Stavropoulos P, Hatziolou E, et al. Coexistence of pemphigus vulgaris, malignant melanoma and low grade lymphoma. Dermatologica 1991; 183: 49-52.
6. Ryan JG. Pemphigus: a 20 year survey of experience with 70 cases. Arch Dermatol 1971; 104: 14-20.
7. Krain LS. Pemphigus: epidemiologic and survival characteristics of 59 patients, 1955-1973. Arch Dermatol 1974; 110: 862-865.
8. Weissmann V, Feuerman EJ, Joshua H, Hazaz B. The correlation between the antibody titers in sera of patients with pemphigus vulgaris and their clinical state. J Invest Dermatol 1978; 71: 107-109.
9. Krasny SA, Beutner EH, Chorzelski TP. Specificity and sensitivity of indirect and direct immunofluorescent findings in the diagnosis of pemphigus. In: Beutner EH, Chorzelski TP, Kumar V, eds. Immunopathology of the Skin, 3rd edn. New York: Wiley, 1987: 207-247.
10. Rosenberg FR, Sanders S, Nelson CT. Pemphigus, a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976; 112: 962-970.
11. Korman NJ. Pemphigus. Derm Clin 1990; 8: 689-700.
12. Ahmed AR, Moy R. Death in pemphigus. J Am Acad Dermatol 1982; 2: 221-228.
13. Sayama K, Yonehara S, Watanabe Y, Miki Y. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J Invest Dermatol 1994; 103: 330-334.
14. Grando SA, Glukhenky BT, Drannik GN, et al. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 1989; 125: 925-930.
15. Mountz JD, Jianguo W, Cheng J, Zhou T. Autoimmune disease, a problem of defective apoptosis. Arthritis Rheum 1994; 37: 1415-1420.
16. Fonacier LS, Bystryn JC. Regional variations in antigenic properties of skin. J Exp Med 1986; 164: 2125-2130.
17. Ioannides D, Hytiroglou P, Phelps R, Bystryn JC. Regional variation in the expression of pemphigus foliaceus, pemphigus erythematosus and pemphigus vulgaris antigens in human skin. J Invest Dermatol 1991; 96: 159-161.
18. Fitzpatrick RE, Newcomer VD. The correlation of disease activity and antibody titers in pemphigus. Arch Dermatol 1980; 116: 285-290.
19. Bystryn JC. Adjuvant therapy of pemphigus. Arch Dermatol 1984; 120: 941-951.
20. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol 1996; 132: 203-212.
21. Low GJ, Keeling JH. Ionizing radiation-induced pemphigus. Case presentations and literature review. Arch Dermatol 1990; 126: 1319-1323.
22. Ruocco V, Pisani M. Induced pemphigus. Arch Dermatol Res 1982; 274: 123-140.
23. Younus J, Ahmed AR. The relationship of pemphigus to neoplasia. J Am Acad Dermatol 1990; 23: 498-502.
24. Katzenelson V, David M, Zamir R, et al. Familial pemphigus vulgaris. Dermatologica 1990; 181: 48-50.
25. Zervas J, Tosca A, Apostolakis I, Vareltzidis A. HLA and pemphigus. Br J Dermatol 1979; 101: 357-358.
26. Ahmed AR, Wagner R, Khatri K, et al. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad. Scv. USA 1991; 88: 5056-5060.